相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Estrogen Receptor Ligands Ameliorate Fatty Liver Through a Nonclassical Estrogen Receptor/Liver X Receptor Pathway in Mice
Song-iee Han et al.
HEPATOLOGY (2014)
Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc
Toshihiro Kai et al.
PLOS ONE (2014)
Impacts of the apoptosis inhibitor of macrophage (AIM) on obesity-associated inflammatory diseases
Satoko Arai et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
MafB promotes atherosclerosis by inhibiting foam-cell apoptosis
Michito Hamada et al.
NATURE COMMUNICATIONS (2014)
Obesity-Associated Autoantibody Production Requires AIM to Retain the Immunoglobulin M Immune Complex on Follicular Dendritic Cells
Satoko Arai et al.
CELL REPORTS (2013)
Apoptosis inhibitor of macrophage (AIM) diminishes lipid droplet-coating proteins leading to lipolysis in adipocytes
Yoshihiro Iwamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
17β-Estradiol enhances response of mice spleen B cells elicited by TLR9 agonist
Yixin Xu et al.
CELLULAR IMMUNOLOGY (2012)
Molecular Mechanisms of Estrogen Receptors' Suppression of Lipogenesis in Pancreatic β-Cells
Joseph P. Tiano et al.
ENDOCRINOLOGY (2012)
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Gyoergy Baffy et al.
JOURNAL OF HEPATOLOGY (2012)
Nonalcoholic Steatohepatitis and Noncirrhotic Hepatocellular Carcinoma: Fertile Soil
Dawn M. Torres et al.
SEMINARS IN LIVER DISEASE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
AIMing at Metabolic Syndrome - Towards the Development of Novel Therapies for Metabolic Diseases via Apoptosis Inhibitor of Macrophage (AIM)
Toru Miyazaki et al.
CIRCULATION JOURNAL (2011)
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Macrophage-Derived AIM Is Endocytosed into Adipocytes and Decreases Lipid Droplets via Inhibition of Fatty Acid Synthase Activity
Jun Kurokawa et al.
CELL METABOLISM (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: Our case series and literature review
Yoshitaka Takuma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease
Joe Gray et al.
BMC CANCER (2009)
Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients?
A. L. Chagas et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Hepatocellular Carcinomas in Patients With Metabolic Syndrome Often Develop Without Significant Liver Fibrosis: A Pathological Analysis
Valerie Paradis et al.
HEPATOLOGY (2009)
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
Natsuko Kawada et al.
JOURNAL OF GASTROENTEROLOGY (2009)
17β-Estradiol Enhances the Response of Plasmacytoid Dendritic Cell to CpG
Xiaoxi Li et al.
PLOS ONE (2009)
Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice
Galyna Bryzgalova et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers
Won Kon Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2008)
Novel serum biomarker candidates for liver fibrosis in hepatitis C patients
Bevin Gangadharan et al.
CLINICAL CHEMISTRY (2007)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: A possible mechanism is through direct regulation of signal transducer and activator of transcription 3
H Gao et al.
MOLECULAR ENDOCRINOLOGY (2006)
A role for the apoptosis inhibitory factor AIM/Spα/Api6 in atherosclerosis development
S Arai et al.
CELL METABOLISM (2005)
Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis
AF Valledor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue
L Lundholm et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
LXR-dependent gene expression is important for macrophage survival and the innate immune response
SB Joseph et al.
CELL (2004)
Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II)
D Grady et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease
F Grodstein et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
